Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 May 2020

Dear Health Sciences applicant
 
At the University of the Free State (UFS), we understand that the current COVID-19 situation is raising many questions for a matriculant who wishes to apply for university study in 2021. We acknowledge the concerns you may have and would like to share important information that should put your mind at ease:
 
1.     The due date for applying to the Faculty of Health Sciences remains 31 May 2020.
 
2.     The following will not be a requirement when applying to study at the UFS in 2021:
 
-          NBT test results
-          Grade 12 June examination results
 
3.     The following is required for application to study at the UFS in 2021 and must accompany your application for admission:
 
-          Grade 11 final examination results  
 
4.     The following supporting documents that you are required to submit together with your application, may be forwarded to FHSApplications@ufs.ac.za at a later stage when the lockdown level makes it possible for you to have these forms completed:
 
-          The school value-added form
-          Confirmation of good health by a medical practitioner
-          Only in the case of applying for Occupational Therapy selection: a motivation (no more than 250 words) can be submitted instead of the proof of a visit to an occupational therapy practice.
 
Therefore, we urge you to apply as soon as possible before the deadline and then send the outstanding documents at a later stage.
 
We look forward to receiving your application to study at Kovsies in 2021!

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept